Search Results - "Signoriello, Elisabetta"

Radiological Reporting Systems in Multiple Sclerosis.

Authors: Scaravilli, Alessandra Tranfa, Mario Pontillo, Giuseppe et al.

Source: Applied Sciences (2076-3417); Jul2024, Vol. 14 Issue 13, p5626, 13p

Correction to: Disability assessment using Google Maps.

Authors: Lavorgna, Luigi Iaffaldano, Pietro Abbadessa, Gianmarco et al.

Source: Neurological Sciences. Feb2022, Vol. 43 Issue 2, p1481-1481. 1p.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing–Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Authors: Abbadessa, Gianmarco Marastoni, Damiano Bile, Floriana et al.

Source: CNS Drugs. Apr2026, Vol. 40 Issue 4, p565-577.

Innovative multidisciplinary tool for screening bowel and bladder symptoms in multiple sclerosis.

Authors: Brichetto, Giampaolo Musco, Stefania Monti Bragadin, Margherita et al.

Source: Neurological Sciences. Mar2025, Vol. 46 Issue 3, p1285-1290. 6p.

Subjects: Delphi method, Bladder diseases, Multiple sclerosis, Bladder, Symptoms

Disability assessment using Google Maps.

Authors: Lavorgna, Luigi Iaffaldano, Pietro Abbadessa, Gianmarco et al.

Source: Neurological Sciences. Feb2022, Vol. 43 Issue 2, p1007-1014. 8p. 1 Diagram, 3 Charts.

Double-negative NMOSD: from case report to a proposed diagnostic and therapeutic algorithm.

Authors: Romano, Giuseppe Lus, Giacomo Cirillo, Mario et al.

Source: BMC Neurology. 11/12/2025, Vol. 25 Issue 1, p1-6. 6p.

Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence.

Authors: Signoriello, Elisabetta Lus, Giacomo Saccà, Francesco et al.

Source: Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 5, p1768. 13p.

Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study.

Authors: Abbadessa, Gianmarco Miele, Giuseppina Di Pietro, Andrea et al.

Source: Neurological Sciences. Apr2022, Vol. 43 Issue 4, p2601-2609. 9p. 4 Charts, 1 Graph.

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.

Authors: Novi, Giovanni Bovis, Francesca Sciolla, Chiara et al.

Source: CNS Drugs. Jul2025, Vol. 39 Issue 7, p693-705.

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.

Authors: Lanzillo, Roberta Carotenuto, Antonio Signoriello, Elisabetta et al.

Source: Journal of Clinical Medicine. Apr2022, Vol. 11 Issue 8, p2081-2081. 9p.

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project.

Authors: Paolicelli, Damiano Borriello, Giovanna Clerici, Raffaella et al.

Source: Neurology & Therapy. Oct2024, Vol. 13 Issue 5, p1415-1430. 16p.

The Efficacy of Fingolimod and Interferons in Controlling Disability and Relapse Rate in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors: Shaygannejad, Vahid Mirmosayyeb, Omid Bagherieh, Sara et al.

Source: International Journal of Preventive Medicine. Jan2024, Vol. 15 Issue 1, p1-10. 10p.

Author Index.

Source: Multiple sclerosis: clinical and laboratory research 2023 Suppl 3; Vol. 29.

Journal Info: Publisher: Sage Publications Inc. ISSN: 1352-4585

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.

Authors: Moccia, Marcello Tajani, Andrea Acampora, Rosa et al.

Source: PLoS ONE. 9/19/2019, Vol. 14 Issue 9, p1-12. 12p.

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis.

Authors: Carotenuto, Antonio Moccia, Marcello Costabile, Teresa et al.

Source: Scientific Reports. Dec2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Authors: Messina, Silvia Solaro, Claudio Righini, Isabella et al.

Source: PLoS ONE. 8/1/2017, Vol. 12 Issue 8, p1-10. 10p.

Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study.

Authors: Foschi, Matteo Marastoni, Damiano Panzera, Ivan et al.

Source: Therapeutic advances in neurological disorders Mar2025; Vol. 18 (1).

Journal Info: Publisher: Sage Publications Inc. ISSN: 1756-2856

Switch from fingolimod to ozanimod for safety or intolerance reasons.

Authors: Signoriello, Elisabetta Romano, Giuseppe Foschi, Matteo et al.

Source: Therapeutic advances in neurological disorders Mar2025; Vol. 18 (1).

Journal Info: Publisher: Sage Publications Inc. ISSN: 1756-2856

Identifying Cladribine prescription pattern in MS: an Italian multicentre study.

Authors: Zanghì, Aurora Fantozzi, Roberta Foschi, Matteo et al.

Source: Therapeutic advances in neurological disorders Mar2025; Vol. 18 (1).

Journal Info: Publisher: Sage Publications Inc. ISSN: 1756-2856

Disability assessment using Google Maps.

Authors: Lavorgna, Luigi Iaffaldano, Pietro Abbadessa, Gianmarco et al.

Source: Neurological Sciences. Jun2021, p1-8. 1p.